OPTIMIZATION OF RECOMBINANT ANTIBODY PRODUCTION IN CHO CELLS

Recombinant antibody production leverages Chinese hamster ovary (CHO) cells due to their robustness in expressing complex biologics. Enhancing these processes involves modifying various variables, including cell line development, media formulation, and bioreactor conditions. A key goal is to maximize antibody production while minimizing production